EPO and anemia: The reduction of endogenous erythropoietin, impaired iron absorption, increased hepcidin levels, increased levels of uremic toxins that cause a reduced bone marrow response to EPO, systemic inflammation conditions, and vitamin deficiencies are some of the underlying mechanisms of anemia in CKD [13].